Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Engineered for implants up to 1500cc, the next-generation delivery system supports a “no-touch” technique to improve control, reduce friction, and minimize risks such as infection and capsular contracture.
Sciton shares how its treatment platforms and post-sale services are designed to help private practices improve clinical outcomes and long-term business performance.
Preservé offers plastic surgeons a minimally invasive approach to breast augmentation with enhanced tissue preservation.
The investment will help scale the company’s 2910 nm fiber laser platforms, designed for use across all skin types.
Dynavisc adhesion barrier gel is designed to reduce the formation of adhesions following tendon and peripheral nerve related surgical procedures.